BridgeMD
New treatment option for Dementia
Official title Case-Finding for Neurocognitive Disorders in Pavia
ClinicalTrials.gov ID: NCT06983119
What this study is testing
- What it's testing
- Dementia is a global public health challenge with a heavy caregiving burden, impacting families, communities, and healthcare systems. It is a priority in healthcare planning, with focus on early diagnosis and ongoing support.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- For the Primary Outcome the are:
- Age 50 or older
- Assessment conducted using GPcog/ACE-III depending on the setting
- No prior diagnosis of cognitive decline
- Ability to understand the study objectives and sign an informed consent For the Primary Outcome the
You likely can't join if
- are:
- Age under 50
- Presence of a diagnosis of cognitive decline
- Limited knowledge of the Italian language For the secondary outcome the inclusion criteria are: Patient:
- All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the...
- Ability to understand the aims of the study and to sign an informed consent Caregiver:
See the full eligibility criteria
- For the Primary Outcome the are:
- Age 50 or older
- Assessment conducted using GPcog/ACE-III depending on the setting
- No prior diagnosis of cognitive decline
- Ability to understand the study objectives and sign an informed consent For the Primary Outcome the
- are:
- Age under 50
- Presence of a diagnosis of cognitive decline
- Limited knowledge of the Italian language For the secondary outcome the inclusion criteria are: Patient:
- All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina;
- Ability to understand the aims of the study and to sign an informed consent Caregiver:
- Age equal to or greater than 18 years
- Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the...
- Acceptance of informed consent and voluntary participation in the study. Healthcare professionals:
- All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and...
- Acceptance of informed consent and voluntary participation in the study. Fo the Secondary Outcome the exclusion criteria are: Patient: \- Inability to understand the aims of the study and to sign an informed consent...
- Age under 18
- Formal caregivers, i.e. any person who provides assistance to the patient in exchange for payment of a fee;
- Caregivers with limited knowledge of the Italian language.
The study team makes the final eligibility decision.
Where it's taking place
- Pavia, Pavia, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pavia, Pavia, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.